Glioblastoma vaccine tumor therapy research progress

Glioblastoma (GBM) is the most common primary malignancy of the central nervous system in adults. The prognosis for late-stage glioblastoma (World Health Organization grade IV astrocytic glioma) is very poor. Novel treatment options are sought after and evaluated by clinicians and researchers, and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tong, Li, Chunwang, Ge, Hongliang, Lin, Yuanxiang, Kang, Dezhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766628/
https://www.ncbi.nlm.nih.gov/pubmed/35045874
http://dx.doi.org/10.1186/s41016-021-00269-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766628/
https://www.ncbi.nlm.nih.gov/pubmed/35045874
http://dx.doi.org/10.1186/s41016-021-00269-7

Ejemplares similares